MA56543A - Formulations de pénétration transdermique - Google Patents

Formulations de pénétration transdermique

Info

Publication number
MA56543A
MA56543A MA056543A MA56543A MA56543A MA 56543 A MA56543 A MA 56543A MA 056543 A MA056543 A MA 056543A MA 56543 A MA56543 A MA 56543A MA 56543 A MA56543 A MA 56543A
Authority
MA
Morocco
Prior art keywords
transdermal penetration
formulations
penetration formulations
transdermal
penetration
Prior art date
Application number
MA056543A
Other languages
English (en)
Inventor
Ryan Beal
Nathan Fitzsimmons
Brandon Sand
Original Assignee
Dyve Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyve Biosciences Inc filed Critical Dyve Biosciences Inc
Publication of MA56543A publication Critical patent/MA56543A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA056543A 2019-06-18 2020-06-18 Formulations de pénétration transdermique MA56543A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962863242P 2019-06-18 2019-06-18

Publications (1)

Publication Number Publication Date
MA56543A true MA56543A (fr) 2022-04-27

Family

ID=74040682

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056543A MA56543A (fr) 2019-06-18 2020-06-18 Formulations de pénétration transdermique

Country Status (12)

Country Link
US (1) US20220105062A1 (fr)
EP (1) EP3986464A4 (fr)
JP (1) JP2022537711A (fr)
KR (1) KR20220054284A (fr)
CN (1) CN115379859A (fr)
AU (1) AU2020298248A1 (fr)
BR (1) BR112021025545A2 (fr)
CA (1) CA3144006A1 (fr)
IL (1) IL289047A (fr)
MA (1) MA56543A (fr)
MX (1) MX2021015830A (fr)
WO (1) WO2020257537A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220202844A1 (en) * 2020-12-31 2022-06-30 Richard Clark Kaufman Drug delivery composition and a method of administering the drug
WO2022155341A1 (fr) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Formulations transdermiques pour inhibiteurs de phosphodiestérase-5
JP2024503463A (ja) * 2021-01-13 2024-01-25 ダイブ バイオサイエンシーズ，インク． 薬剤投与用の経皮浸透製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2262009A1 (fr) * 1996-07-23 1998-01-29 Wilson T. Crandall Transport transdermique de molecules
WO2009092040A2 (fr) * 2008-01-17 2009-07-23 Gary Dean Bennett Formulation de douleur topique
CN105664223B (zh) * 2009-10-26 2018-12-04 日产化学工业株式会社 化妆料、皮肤外用剂、以及医疗用仪器
KR101836877B1 (ko) * 2014-10-30 2018-03-09 데루타-후라이 화마 가부시키가이샤 국소 투여용 리포플렉스의 신규 제조 방법 및 상기 리포플렉스를 사용하는 항 종양제
EP3915542B1 (fr) * 2014-12-23 2023-11-22 Dyve Biosciences, Inc. Formulations pour l'administration transdermique
KR20180105199A (ko) * 2016-01-23 2018-09-27 앰퍼샌드 바이오파마슈티컬스, 인크. 활성 제제의 경피 전달 증대
BR112018070140A2 (pt) * 2016-03-31 2019-02-05 Smartech Topical, Inc. sistema de distribuição
WO2019055880A2 (fr) * 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Méthode d'administration et de traitement
EP3860570A4 (fr) * 2018-10-05 2022-10-12 Ampersand Biopharmaceuticals, Inc. Formulations et procédés d'administration transdermique de cétones
EP3860621A4 (fr) * 2018-10-05 2022-07-06 Ampersand Biopharmaceuticals, Inc. Formulations de fer pour administration topique et procédés de traitement d'une déficience en fer
WO2020086766A1 (fr) * 2018-10-23 2020-04-30 Ampersand Biopharmaceuticals, Inc. Méthodes et formulations pour l'administration transdermique d'agents de remodelage dermique

Also Published As

Publication number Publication date
MX2021015830A (es) 2022-04-11
CA3144006A1 (fr) 2020-12-24
WO2020257537A1 (fr) 2020-12-24
JP2022537711A (ja) 2022-08-29
KR20220054284A (ko) 2022-05-02
IL289047A (en) 2022-02-01
EP3986464A1 (fr) 2022-04-27
US20220105062A1 (en) 2022-04-07
AU2020298248A1 (en) 2022-02-03
CN115379859A (zh) 2022-11-22
BR112021025545A2 (pt) 2022-02-22
EP3986464A4 (fr) 2023-07-05

Similar Documents

Publication Publication Date Title
EP3900658C0 (fr) Dispositif d'ablation multipolaire
EP3989959A4 (fr) Formulations transdermiques
MA50657A (fr) Formulations de niraparib
EP3741296A4 (fr) Bioélectrode
EP3744897A4 (fr) Dispositif de consolidation de sol
IL273087A (en) Transdermal compositions
EP4013441A4 (fr) Formulations de larazotide
MA56543A (fr) Formulations de pénétration transdermique
EP3391884C0 (fr) Préparation absorbable par voie transdermique
MA50068A (fr) Formulations de copanlisib
EP3377067A4 (fr) Formulation de pénétration cutanée à base de taurolidine
CL2018002038S1 (es) Cultivador
DK3911298T3 (da) Formuleringer
EP3810137A4 (fr) Formulations de nitroimidazole
EP3706731A4 (fr) Formulations améliorées de médicaments
EP4046650A4 (fr) Patch de type absorption transdermique
EP3941442A4 (fr) Formulations de supraparticules
EP3741295A4 (fr) Bioélectrode
EP3723729C0 (fr) Formulation analgésique transdermique
UA41916S (uk) Культиватор
UA41908S (uk) Культиватор
UA41909S (uk) Культиватор
UA40634S (uk) Культиватор
UA40550S (uk) Культиватор
UA40635S (uk) Культиватор